Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia. [electronic resource]
Producer: 20020513Description: 295-300 p. digitalISSN:- 1053-8569
- Anti-Ulcer Agents -- economics
- Antidepressive Agents, Second-Generation -- economics
- Australia
- Cohort Studies
- Drug Costs
- Drug Prescriptions -- economics
- Drugs, Generic -- economics
- Fluoxetine -- economics
- Humans
- Insurance, Pharmaceutical Services -- economics
- National Health Programs -- economics
- Ranitidine -- economics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.